Voya Investment Management LLC increased its holdings in shares of Tenet Healthcare Corporation (NYSE:THC – Free Report) by 346.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 162,756 shares of the company’s stock after acquiring an additional 126,283 shares during the period. Voya Investment Management LLC owned about 0.20% of Tenet Healthcare worth $41,594,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in THC. Global Retirement Partners LLC lifted its position in shares of Tenet Healthcare by 24.8% during the third quarter. Global Retirement Partners LLC now owns 1,475 shares of the company’s stock worth $377,000 after purchasing an additional 293 shares in the last quarter. Rothschild Investment LLC lifted its holdings in Tenet Healthcare by 124.4% during the 3rd quarter. Rothschild Investment LLC now owns 918 shares of the company’s stock worth $235,000 after buying an additional 509 shares in the last quarter. Cibc World Market Inc. boosted its position in Tenet Healthcare by 129.4% in the 3rd quarter. Cibc World Market Inc. now owns 26,118 shares of the company’s stock valued at $6,675,000 after buying an additional 14,734 shares during the last quarter. Bessemer Group Inc. lifted its stake in shares of Tenet Healthcare by 5.1% during the third quarter. Bessemer Group Inc. now owns 892 shares of the company’s stock valued at $227,000 after acquiring an additional 43 shares during the period. Finally, Hantz Financial Services Inc. lifted its stake in shares of Tenet Healthcare by 21.4% during the third quarter. Hantz Financial Services Inc. now owns 5,068 shares of the company’s stock valued at $1,295,000 after acquiring an additional 895 shares during the period. Institutional investors own 95.44% of the company’s stock.
Insider Activity at Tenet Healthcare
In related news, CEO Saumya Sutaria sold 50,000 shares of Tenet Healthcare stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $278.71, for a total value of $13,935,500.00. Following the sale, the chief executive officer owned 483,564 shares of the company’s stock, valued at approximately $134,774,122.44. The trade was a 9.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard J. Mark sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $263.42, for a total value of $2,634,200.00. Following the completion of the transaction, the director owned 25,121 shares of the company’s stock, valued at approximately $6,617,373.82. This represents a 28.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 99,462 shares of company stock worth $27,081,234. 0.97% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
Several research analysts have recently issued reports on THC shares. Stephens reaffirmed an “overweight” rating and issued a $285.00 target price on shares of Tenet Healthcare in a research note on Monday, July 27th. Morgan Stanley raised their price target on Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research report on Monday, July 27th. Mizuho set a $305.00 target price on Tenet Healthcare in a research report on Monday, November 2nd. Piper Sandler set a $308.00 price target on shares of Tenet Healthcare in a research report on Monday, July 27th. Finally, Robert W. Baird increased their target price on shares of Tenet Healthcare from $210.00 to $280.00 and gave the stock a “neutral” rating in a report on Tuesday, July 28th. Nineteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $296.65.
View Our Latest Analysis on THC
Tenet Healthcare Trading Down 2.9%
Shares of NYSE:THC opened at $263.57 on Friday. The firm has a market cap of $20.98 billion, a price-to-earnings ratio of 7.64, a PEG ratio of 1.45 and a beta of 1.20. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 1.76. Tenet Healthcare Corporation has a 12 month low of $157.58 and a 12 month high of $301.44. The company’s fifty day simple moving average is $268.85 and its 200 day simple moving average is $226.64.
Tenet Healthcare (NYSE:THC – Get Free Report) last released its earnings results on Thursday, October 29th. The company reported $6.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.68 by $1.96. The firm had revenue of $6.28 billion during the quarter, compared to analysts’ expectations of $5.49 billion. Tenet Healthcare had a return on equity of 28.22% and a net margin of 13.09%. The company’s revenue was up 6.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.70 EPS. As a group, research analysts forecast that Tenet Healthcare Corporation will post 22.32 EPS for the current fiscal year.
Tenet Healthcare Profile
Tenet Healthcare Corporation is a U.S.-based healthcare services company that operates acute care hospitals and provides related inpatient and outpatient services. Its hospitals offer services across areas such as emergency care, surgery, imaging and specialty treatment. Through its subsidiary United Surgical Partners International (USPI), Tenet also operates ambulatory surgery centers and surgical hospitals, providing outpatient surgical and procedural care. The company’s Conifer Health Solutions business provides revenue cycle management and other administrative services to healthcare providers.
Read More
- Five stocks we like better than Tenet Healthcare
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC – Free Report).
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
